***NEW LDN Science Info Site

[Guest guest]

This is a new LDN Science site owned by

Scientists and Doctors with abstracts of all clinical and

pre-clinical trials on LDN,

OGF and related therapies. This is the best LDN site I have seen by

far. I highly recommend this site to everyone who is

interested in learning about LDN or looking for information to take to

their doctor and share with friends. There is a newsletter

so be sure to sign up for updates.

http://www.ldnscience.org

LDNscience™ is a public information project of the MedInsight® Research

Institute.

The MedInsight® Research Institute is a U.S.-based 501©(3) nonprofit

working to bridge the ever-widening gap between medical research and

actual medical practice. We are dedicated to bringing relief to those

who suffer from cancer or chronic medical conditions by raising

awareness of:

* • Commercially unsponsored medications.

* • Off-label or secondary uses for approved medications.

* • Specialized tests that enable treatments to be tailored to the

individual.

MedInsight's co-founder, Moshe Rogosnitzky, is an expert in the

clinical application of Low Dose Naltrexone (LDN), Opioid Growth Factor

(OGF) and related therapies, which have made incredible inroads

with Crohn’s disease, cancer and other serious diseases. He

collaborates in research with the discoverers of LDN and OGF, Dr.

Ian S. Zagon and Dr. J. McLaughlin of Hershey Medical Center,

Penn State University, as well as with Dr. Jill P. of Hershey

Medical Center, who conducts clinical research into LDN and OGF.

This site is intended to provide you with general information on the

background, use of and evidence for LDN, OGF and related therapies, and

to answer any questions on these therapies and our work. If you cannot

find the answer to your particular question, please submit your

question and we will respond to you as soon as possible.

Garnet

--